Capturing Insightful Oncology Analytics: Optimizing the Market Research Organization

Market research and analytics organizations play a vital role in providing oncology brand teams with the information they need to make better decisions, quicker. In today's complex, rapidly changing oncology marketplace, it is more important than ever that these organizations launch the right activities at the right time with the right level of resources to provide a brand with a competitive edge.

This 40-slide presentation will help pharmaceutical and biotech companies evaluate and improve the effectiveness of their oncology market research and analytics (MR&A) programs.

Industries Profiled:
Pharmaceutical; Biotech; Diagnostic; Chemical; Manufacturing; Consumer Products; Medical Device


Companies Profiled:
Novartis; Genmab; Human Genome Sciences; Eli Lilly and Company; Genentech; Janssen Cilag Pharmaceutical; Ortho Biotech; Daiichi Pharmaceutical Co.; Ltd.; Bayer; Serono

Study Snapshot

This research originated from an original client research for a member of Best Practices, LLC Research and Advisory Services. The research was based on a survey of directors and managers of market research and analytic functions in 11 leading pharmaceutical and biotechnology companies.

Key topics include:

• Distribution of MR&A Resources at each Phase of Drug Development
• Allocation of MR&A Resources across Functions, including Market research, Market Analytics, Forecasting, Competitive Intelligence, and Strategic Business Planning.
• Levels of Market Research Activities by Product Development Phase
• Distribution of Market Research Headcount and Budget by Product Development Phase
• Budget Allocation Trends by MR&A Function
• Level of Outsourcing of Market Research Studies and Projects
• Degree of Centralization of Individual MR&A Functions
• Market Research FTE’s per Oncology Product
• Effective Internal Stakeholder Communication Methods
• Key Lessons Learned - Successes and Risks

Sample Key Findings

A large majority of the benchmark class commissions market research within Phase I of product development.

• On average, the benchmarked companies allocate 20% of their Market Research & Analytics headcount to pre-Phase III activities.

• Outsourcing dominates market research strategy at the benchmarked companies.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.